Skip to content
-
-
-
-
-
- Cardic/Diabtic
-
- What is the Uses of ROSUVIN-F (Rosuvastatin 10 mg + Fenofibrate 160 mg): ROSUVIN-F is a combination medication that contains two active ingredients: rosuvastatin and fenofibrate. This combination is commonly used to manage lipid (cholesterol and triglyceride) levels in the blood. Here are the primary uses of ROSUVIN-F: Hyperlipidemia: ROSUVIN-F is prescribed to treat hyperlipidemia, a condition characterized by elevated…
- Read more
-
-
- Tablets
-
- BROMELAIN 90 MG RUTOISDE 100 MG TRYPSIN 45 MG , DICLOFENAC 100 MG
- Read more
-
-
-
- Cardic/Diabtic
-
- Product Name: TELIVIN–AM Composition: TELMISARTAN 40 MG + AMLODIPINE 5 MG Overview: Telivin–AM is a combination medication that blends Telmisartan and Amlodipine to provide a powerful solution for managing certain cardiovascular conditions. This synergistic formulation is designed to offer dual benefits, targeting hypertension and related issues. Key Components: Telmisartan (40 mg): A potent angiotensin II receptor blocker (ARB) that helps…
- Read more
-
-
- Cardic/Diabtic
-
- Product Name: TELIVIN-40 Composition: TELMISARTAN 40 MG Overview: Telivin-40 is a medication containing Telmisartan, an angiotensin II receptor blocker (ARB), widely used for managing hypertension (high blood pressure) and related cardiovascular conditions. Telmisartan helps relax blood vessels, allowing for improved blood flow and reduced blood pressure. Key Component: Telmisartan (40 mg): An angiotensin II receptor blocker that selectively binds to…
- Read more
-
-
- Cardic/Diabtic
-
- Product Name: TELIVIN-H Composition: TELMISARTAN 40 MG + HYDROCHLOROTHIAZIDE 12.5 MG Overview: Telivin-H is a medication that combines Telmisartan and Hydrochlorothiazide, offering a synergistic approach to managing hypertension and related conditions. This combination is particularly effective in addressing high blood pressure by targeting different aspects of blood pressure regulation. Key Components: Telmisartan (40 mg): An angiotensin II receptor blocker (ARB)…
- Read more
-
-
-